Dr. Anthony Aldave’s primary research interest is investigating the genetic basis of the corneal dystrophies, a group of inherited disorders that cause progressive loss of vision and are the primary indication for corneal transplantation in the United States.
Selected Cancer-Related Publications:
Yellore VS, Rayner SA, Nguyen CK, Gangalum RK, Jing Z, Bhat SP, Aldave AJ. Analysis of the role of ZEB1 in the pathogenesis of posterior polymorphous corneal dystrophy. Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):273-8. Print 2012 Jan.
Yu L, Aldave AJ, Glasgow BJ. Epstein-Barr virus-associated smooth muscle tumor of the iris in a patient with transplant: a case report and review of the literature. Arch Pathol Lab Med. 2009 Aug;133(8):1238-41.
Kamal KM, Rayner SA, Chen MC, Aldave AJ. Classic lattice corneal dystrophy associated with monoclonal gammopathy after exclusion of a TGFBI mutation. Cornea. 2009 Jan;28(1):97-8.
Aldave AJ, Nguyen A. Ocular surface toxicity associated with topical interferon alpha-2b. Br J Ophthalmol. 2007 Aug;91(8):1087-8.
Aldave AJ, King JA, Kim BT, Hopp L. Corneal copper deposition associated with chronic lymphocytic leukemia. Am J Ophthalmol. 2006 Jul;142(1):174-6.